University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Peter Bacchetti, PhD

Peter Bacchetti, PhD

Adjunct Professor, Department of Epidemiology and Biostatistics, UCSF

Cancer Center Program Memberships

Affiliate Member

Education

University of California, Berkeley, California, BA, 1980, Philosophy and Statistics
Stanford University, Stanford, California, MS, 1982, Statistics
University of California, Berkeley, California, PhD, 1987, Biostatistics
 


Professional Experience

  • 11/82-7/85
    Statistician, Department of Epidemiology and Biostatistics, UCSF
  • 8/85-12/87
    Senior Statistician, Department of Epidemiology and Biostatistics, UCSF
  • 1/88-6/93
    Adjunct Assistant Professor, Department of Epidemiology and Biostatistics, UCSF
  • 7/93-7/99
    Adjunct Associate Professor, Department of Epidemiology and Biostatistics, UCSF
  • 11/93-present
    Director, Biostatistical Consulting Unit, Department of Epidemiology and Biostatistics, UCSF
  • 07/99-present
    Adjunct Professor, Department of Epidemiology and Biostatistics, UCSF

Honors & Awards

  • 1980
    Phi Beta Kappa
  • 1980
    Statistics Departmental Citation (outstanding graduating senior), University of California, Berkeley
  • 1988
    First place, Biometric Society 1987-88 student paper competition (Western North American Region)
  • 1998
    Mortimer Spiegelman Award for outstanding contributions to health statistics, American Public Health Association
  • 2004
    Fellow of the American Statistical Association

Selected Publications

  1. Murnane PM, Bacchetti P, Currier JS, Brummel S, Okochi H, Phung N, Louie A, Kuncze K, Hoffman RM, Nematadzira T, Soko DK, Owor M, Saidi F, Flynn PM, Fowler MG, Gandhi M. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. AIDS. 2019 Aug 01; 33(10):1657-1662.
    View on PubMed
  2. Gerona R, Wen A, Aguilar D, Shum J, Reckers A, Bacchetti P, Gandhi M, Metcalfe J. Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS/MS panel. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jul 23; 1125:121729.
    View on PubMed
  3. Tamraz B, Reisner L, French AL, King ST, Fischl MA, Ofotokun I, Kashuba A, Milam J, Murphy K, Augenbraun M, Liu C, Finley PR, Aouizerat B, Cocohoba J, Gange S, Bacchetti P, Greenblatt RM. Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection. Pharmacotherapy. 2019 Jul 22.
    View on PubMed
  4. Drain PK, Kubiak RW, Siriprakaisil O, Klinbuayaem V, Quame-Amaglo J, Sukrakanchana PO, Tanasri S, Punyati P, Sirirungsi W, Cressey R, Bacchetti P, Okochi H, Baeten JM, Gandhi M, Cressey TR. confUrine Tenofovir Concentrations Correlate with Plasma and Relates to TDF Adherence: A Randomized Directly-observed Pharmacokinetic Trial (TARGET Study). Clin Infect Dis. 2019 Jul 17.
    View on PubMed
  5. Velloza J, Bacchetti P, Hendrix CW, Murnane P, Hughes JP, Li M, Curlin M, Holtz TH, Mannheimer S, Marzinke MA, Amico KR, Liu A, Piwowar-Manning E, Eshleman SH, Dye BJ, Gandhi M, Grant RM. Short and long-term pharmacologic measures of HIV pre-exposure prophylaxis use among high-risk men who have sex with men in HPTN 067/ADAPT. J Acquir Immune Defic Syndr. 2019 Jul 04.
    View on PubMed
  6. Kaimal AJ, Grobman WA, Bryant A, Blat C, Bacchetti P, Gonzalez J, Thiet MP, Bermingham Y, Kuppermann M. The association of patient preferences and attitudes with trial of labor after cesarean. J Perinatol. 2019 Jul 03.
    View on PubMed
  7. Gandhi M, Devi S, Bacchetti P, Chandy S, Heylen E, Phung N, Kuncze K, Okochi H, Kumar R, Kurpad AV, Ekstrand ML. Measuring Adherence to Antiretroviral Therapy via Hair Concentrations in India. J Acquir Immune Defic Syndr. 2019 Jun 01; 81(2):202-206.
    View on PubMed
  8. Kaimal AJ, Grobman WA, Bryant AS, Norrell L, Bermingham Y, Altshuler A, Thiet MP, Gonzalez J, Bacchetti P, Moghadassi M, Kuppermann M. Women's Preferences Regarding the Processes and Outcomes of Trial of Labor After Cesarean and Elective Repeat Cesarean Delivery. J Womens Health (Larchmt). 2019 May 21.
    View on PubMed
  9. Metcalfe J, Bacchetti P, Gerona R, Esmail A, Dheda K, Gandhi M. Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB. ERJ Open Res. 2019 Apr; 5(2).
    View on PubMed
  10. Rosenbloom DIS, Bacchetti P, Stone M, Deng X, Bosch RJ, Richman DD, Siliciano JD, Mellors JW, Deeks SG, Ptak RG, Hoh R, Keating SM, Dimapasoc M, Massanella M, Lai J, Sobolewski MD, Kulpa DA, Busch MP. Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size. PLoS Comput Biol. 2019 04; 15(4):e1006849.
    View on PubMed
  11. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS. 2019 Apr 01; 33(5):825-832.
    View on PubMed
  12. Scully EP, Gandhi M, Johnston R, Hoh R, Lockhart A, Dobrowolski C, Pagliuzza A, Milush JM, Baker CA, Girling V, Ellefson A, Gorelick R, Lifson J, Altfeld M, Alter G, Cedars M, Solomon A, Lewin SR, Karn J, Chomont N, Bacchetti P, Deeks SG. Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation. J Infect Dis. 2019 Mar 15; 219(7):1084-1094.
    View on PubMed
  13. Gandhi M, Bacchetti P, Ofokotun I, Jin C, Ribaudo HJ, Haas DW, Sheth AN, Horng H, Phung N, Kuncze K, Okochi H, Landovitz RJ, Lennox J, Currier JS. Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial. Clin Infect Dis. 2019 Mar 05; 68(6):1044-1047.
    View on PubMed
  14. Selby K, Jensen CD, Zhao WK, Lee JK, Slam A, Schottinger JE, Bacchetti P, Levin TR, Corley DA. Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study. Clin Transl Gastroenterol. 2019 Feb; 10(2):e00010.
    View on PubMed
  15. Gandhi M, Bacchetti P, SpinelliI MA, Okochi H, Baeten JM, Siriprakaisil O, Klinbuayaem V, Rodrigues WC, Wang G, Vincent M, Cressey TR, Drain PK. Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cut-Off for a Point-of-Care Test. J Acquir Immune Defic Syndr. 2019 Jan 11.
    View on PubMed
  16. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Opsina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. RAPID ART: High virologic suppression rates with immediate ART initiation in a vulnerable urban clinic population. AIDS. 2018 Dec 21.
    View on PubMed
  17. Lee SA, Elliott JH, McMahon J, Hartogenesis W, Bumpus NN, Lifson JD, Gorelick RJ, Bacchetti P, Deeks SG, Lewin SR, Savic RM. Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial. Clin Pharmacol Ther. 2019 Mar; 105(3):692-702.
    View on PubMed
  18. Koss CA, Liu AY, Castillo-Mancilla J, Bacchetti P, McHugh C, Kuncze K, Morrow M, Louie A, Seifert S, Okochi H, MaWhinney S, Gandhi M, Anderson PL. Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoring. AIDS. 2018 Sep 24; 32(15):2189-2194.
    View on PubMed
  19. Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort. J Gen Intern Med. 2018 Sep 20.
    View on PubMed
  20. Gandhi M, Bacchetti P, Rodrigues WC, Spinelli M, Koss CA, Drain PK, Baeten JM, Mugo NR, Ngure K, Benet LZ, Okochi H, Wang G, Vincent M. Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence. EClinicalMedicine. 2018 Aug-Sep; 2-3:22-28.
    View on PubMed

Go to UCSF Profiles, powered by CTSI